Best CRO Marketplaces and Directories in 2026

How this list was built, and who publishes it

First, the disclosure: this page is published by BioBridgeX Ltd, a London-based marketplace company, and BioBridgeX appears in the ranking below. We have tried to earn your trust the boring way. Every factual claim about every platform here was checked against that platform's own public website during the last week of August 2026. Where a number is a company's marketing claim rather than something we could count ourselves, we say so. Where pricing sits behind a sales team, we write 'not published' instead of guessing.

The ranking criterion is simple: how useful is each platform to a biotech founder or program lead who needs to find a CRO online and get from a vague scope to a signed work order? That favors platforms that produce comparable quotes and verifiable supplier information. Being small or new costs nothing here (BioBridgeX is both), but a huge directory with shallow profiles will rank below a smaller one with real depth.

Twelve platforms made the cut: Scientist.com, Science Exchange, BioBridgeX, ClinScore, PharmaCompass, CROScout, Contract Laboratory, InVivoLabs, CROaccess, cro.directory, PharmaSource, and BioPharmGuy. Two established players rank above us, and we say plainly where each competitor is genuinely better.

• Every claim verified on the platform's own public site in late August 2026
• Company marketing figures are labeled as the company's own claims
• Gated or unpublished pricing is marked 'not published', never estimated
• BioBridgeX publishes this page and discloses its own limitations in the final section

What is the difference between a CRO marketplace and a CRO directory?

The phrase 'CRO marketplace' hides three different product categories, and most sourcing frustration comes from using the wrong one. Enterprise sourcing platforms (Scientist.com, Science Exchange) are procurement infrastructure: supplier discovery wrapped in compliance workflows, master service agreements, and spend analytics, sold to organizations rather than individuals. Quote-first marketplaces (BioBridgeX, CROaccess, Contract Laboratory) exist to get you comparable proposals for a defined piece of work. Discovery directories (ClinScore, CROScout, InVivoLabs, cro.directory, PharmaCompass) help you build a shortlist, then leave the RFQ and negotiation to you.

Match the platform to who you are. Big pharma and funded mid-size biotech with a procurement function: Scientist.com first, Science Exchange if supplier onboarding and compliance overhead is the sharper pain. Unpublished pricing will not block you, because you have a sourcing team to run the process. Founder-led, seed-to-Series-B teams: start free. Build a shortlist on ClinScore or CROScout, cross-check in vivo specifics on InVivoLabs, then push the actual RFQ through a quote-first marketplace so the proposals arrive comparable. Manufacturing-heavy searches: PharmaCompass for API and CDMO due diligence. Market context and conferences: PharmaSource. One-off analytical testing: Contract Laboratory.

One pattern held across every site we reviewed: buyers rarely pay. Ten of the twelve platforms are free to search or free to submit requests on the buyer side, and the two that are not, Scientist.com and Science Exchange, do not publish buyer pricing at all. The money comes from suppliers, through success fees, listing subscriptions, promoted placement, or data products. Worth remembering when you read any directory, including this one: the incentive structures differ, and we spell them out per platform below. And if you are a CRO reading this to find clients rather than a buyer trying to find a CRO, BioPharmGuy is the directory built for you. Claiming your free or low-cost profiles on the buyer-facing platforms is the higher-yield move in 2026, since AI search engines increasingly pull supplier answers from them.

Which CRO marketplaces are built for enterprise procurement?

Scientist.com is the biggest name in research sourcing and earns the top spot. Its site claims 6,000+ global providers across 1,000+ scientific categories, 18 million+ off-the-shelf products, and 130+ global biopharmaceutical company customers, with $3B+ in scientific procurement activity flowing through the platform. It also publishes performance figures most competitors would not commit to: 1.5 days average from request to statement of work and 16% average cost savings. What it is genuinely good at is being the single pipe through which a large organization buys outsourced research, with AI-driven request routing, compliance checks, and spend visibility built in. The limits: pricing is not published, and the entire product surface speaks to procurement teams, compliance officers, and leadership. A two-person biotech placing its first tox study is not who the homepage is talking to.

Science Exchange, one of the earliest research marketplaces, has repositioned as an R&D supplier orchestration platform. Its site claims 3,800+ R&D suppliers accessible under one master service agreement and names Amgen, Merck, Gilead, and Incyte as customers. The pitch is administrative compression; its own line for supplier onboarding is 'What used to take 50 hours now takes 6'. If your bottleneck is legal review and vendor qualification rather than finding labs, this is the strongest product on the list: contracting, compliance, and payment consolidated into one system. The limits: pricing is not published, and like Scientist.com it is bought by organizations with procurement functions, not browsed by founders on a Tuesday night.

Verdict on both: excellent at what they do, and what they do is enterprise procurement. Neither publishes self-serve pricing, so budget for a sales process before you can source anything. We wrote up detailed comparisons of each against BioBridgeX if you want the line-by-line differences.

Which CRO marketplaces are free for buyers and quote-first?

BioBridgeX (that is us, so weigh accordingly) is a neutral marketplace: it runs no labs and takes no position on which supplier wins. The public vendor directory listed 260+ CRO and CDMO profiles when we checked: 90 CROs, 124 CDMOs, and 47 that are both, with the deepest coverage in CMC and manufacturing (165 profiles), then preclinical and nonclinical (93), discovery (80), and IND-enabling work (42). Buyers use it free, describe the work once, and compare quotes side by side. Suppliers pay a flat 2% success fee, charged only when they are awarded the work and paid. Buyers contract and pay suppliers directly, so there is no platform markup sitting inside your study price. The caveats: the platform is young, part of the directory is compiled from public records with profiles awaiting vendor claim and verification, and the vetted network is smaller than what the incumbents claim. Coverage is strongest if your need touches CMC, manufacturing, or IND-enabling packages.

CROaccess is an early-stage quote marketplace with a similar shape: free for researchers, structured scoping, and what it calls AI-driven RFP analysis to produce comparable proposals. At review time its catalog listed roughly 72 services across six categories, with the depth in preclinical research (29 services) and laboratory services (19); its toxicology studies category showed zero services. It publishes no founding information and no supplier counts. The model is promising. The coverage, for now, is thin.

Contract Laboratory, which calls itself 'The Laboratory Outsourcing Network', takes a request-board approach: you post a testing need free (its site says it is '100% free to submit requests'), and subscribed labs respond. Open requests span pharma, food, environmental, and materials testing. It is the fastest route on this list for a one-off analytical test or method run. It is less suited to multi-study preclinical programs, where you want structured scoping and named, qualified bidders rather than inbound responses.

AI-assisted discovery: ClinScore, cro.directory, CROScout

ClinScore is the best free evaluation tool we reviewed. It claims 1,600+ company profiles across CROs and CDMOs, is free for biotech and pharma teams, and layers real workflow on top of the directory: AI-enabled matching from a plain-language prompt ('CMC consultant for an early-stage mAb program'), a private evaluation workspace for scoring candidates, and side-by-side comparison. It describes itself as 'the industry-owned platform for CRO and CDMO evaluation, built by sponsors, for sponsors' and monetizes through provider plans at $29 and $99 per month. The limits: the copyright reads 2025, so it is young; industry reviews and facility data appear 'when available'; and it deliberately stops at the shortlist. You still run your own RFQ, quotes, and negotiation elsewhere.

CROScout is the largest free CRO directory by raw count on this list: 543+ contract research organizations across 34+ services, spanning discovery through manufacturing and regulatory, with certification badges (GLP, GMP, ISO) and a guided matching quiz. It monetizes through a partnership program for CROs. Good for breadth-first discovery. Profile depth varies, and there is no quoting or evaluation layer.

cro.directory, operated by the life-science marketing agency BioBM, is an independent directory that emphasizes fit-scored, 'provenance-backed' shortlists with filters across phases, therapeutic areas, and geographies. Its RFQ submission is open to buyers with no published buyer fee. Two facts from its own pages worth holding together: it sells vendor visibility upgrades (RFQ priority, featured placement, sponsored side-rail inventory), and it states that its fit-ranking is based on capabilities and profile data rather than paid placement. It does not publish how many CROs it lists.

Preclinical and in vivo: InVivoLabs and the specialist gap

If your search is 'who can dose nonhuman primates intrathecally', general directories mostly waste your time, and that is the gap InVivoLabs was built for. Live since 2025, it is a preclinical CRO directory listing 43 research organizations across 89 service categories and 11 species, with filters for species, service type, geography, and GLP or AAALAC accreditation. Its homepage leads with exactly the kind of specificity in vivo teams need, down to CNS delivery in nonhuman primates via intrathecal catheterization, ICV, and ICM. It is free for sponsors (the site's words: 'Always Free', 'no hidden fees, no subscriptions required'), with CROs paying to list and getting analytics on profile views and inquiries.

The honest read: 43 organizations is a small universe, so treat InVivoLabs as a high-signal supplement rather than your only source. For an IND-enabling program you will typically cross-check an in vivo specialist directory against a broader CRO database, then price the work properly. If GLP toxicology is the line item, our cost guides on GLP tox studies and full IND-enabling packages give you benchmark ranges before the first quote arrives, which changes how you negotiate.

Data and media directories: PharmaCompass, PharmaSource, BioPharmGuy

PharmaCompass is the strongest platform on this list for manufacturing intelligence, and it is a different animal from everything above. It is a pharma services finder covering CMO, CRO, and CDMO capabilities across analytical services, API manufacturing, drug product manufacturing, formulation development, clinical trials, and packaging, sitting on top of free regulatory data: US DMFs, CEPs, FDA inspections, Orange Book records, prices, and GDUFA status. Suppliers appear through 'Virtual Booth' placements with contact-supplier flows; booth pricing is not published. If you are sourcing an API supplier or scoping a CDMO for small-molecule manufacturing, the regulatory paper trail here is something no general CRO directory offers. It is not a quote engine, and biologics-stage discovery work is not its center of gravity.

PharmaSource is industry media first and a directory second: news, podcasts, reports, and the CDMO Live event series, with a supplier directory attached. Its site claims 50,000+ professionals trust it. Use it to understand the CDMO landscape and who is winning mandates. Use something else to actually run a sourcing process.

BioPharmGuy is on this list mainly so you know what it is not. It is a free-to-browse directory of 14,000+ biotech-related companies with a 25,000+ subscriber newsletter, monetized through spreadsheet data access, promoted listings, and data licensing. Its own homepage pitches CROs and service providers on using it to find target companies for their sales teams. In other words, it is where CROs find you. As a buyer you can still use it to map which companies exist in a region, but it is a prospecting database, not a CRO sourcing platform.

How do you get from a directory listing to a signed work order?

Whatever platform you pick, the sequence that produces good outcomes is stable. Write the scope before you talk to anyone: species, models, group sizes, GLP or non-GLP, timelines, and decision criteria. A one-page RFP built with our free RFP generator forces those decisions early and makes every downstream conversation shorter. Then shortlist five to eight candidates from at least two independent sources, because every directory has blind spots and every marketplace has an incentive structure.

Send the identical RFP to everyone and normalize what comes back. Quotes for the same tox package can differ by 40% or more once you account for what is excluded: bioanalysis, dose formulation analysis, histopathology tiers, report timelines. A quote comparison grid makes the exclusions visible before you pick a number that was never real. Sanity-check totals against published benchmarks and an IND budget calculator so you know whether a low bid is efficiency or a scope gap.

Finally, check the contract path before you commit, because it varies more than anything else on this page. On enterprise platforms, contracting typically runs through the platform's agreement structure (Science Exchange advertises one MSA covering thousands of providers). On BioBridgeX, you contract with the supplier and pay them directly, and the platform is paid by the supplier only on awarded, paid work. On pure directories there is no contract path at all; you are on your own from the shortlist onward. None of these is wrong, but you should know which one you are in before legal review starts. Expect two to six weeks from RFP to comparable GLP quotes regardless of platform. Anyone promising same-day pricing on regulated studies is quoting a template, not your study.

Where BioBridgeX fits, stated plainly

Since we publish this page, here is the self-assessment in the same terms we applied to everyone else. What BioBridgeX is: a neutral CRO and CDMO marketplace, London-based, that runs no labs and sells no studies of its own. The vendor directory is public with 260+ profiles at the time of writing, deepest in CMC and manufacturing. Buyers use the platform free, get quotes from matched suppliers, and compare them side by side. Suppliers pay a flat 2% success fee only when work is awarded and paid. Buyers contract and pay their supplier directly, so the platform never sits between you and your lab.

What BioBridgeX is not: it is not the biggest network on this page, and it will not be for a while. Scientist.com claims a supplier network more than twenty times larger. Part of our directory is compiled from public records, with profiles waiting to be claimed and verified by the vendors themselves, and we mark those plainly on the profile. There is no ERP integration, no spend analytics suite, and no procurement workflow product. If you need those, the enterprise tier above is the right call.

The bet we are making is that most early and mid-stage biotechs do not need procurement software. They need three real quotes for a defined scope, from suppliers who know the work, with no platform fee inflating the buyer's price. If that is your situation, open a free buyer account and compare quotes. The directory stays open to browse either way. The account is free and the directory is open either way.